Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2026-01-06 Delisting Announcement
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Delisting Announcement Classification · 1% confidence The document is a press release announcing the judicial liquidation of CARMAT SA and the subsequent delisting of its shares from Euronext Growth. While it mentions the liquidation process, the primary regulatory impact and the specific nature of the announcement is the removal of the company's stock from the exchange. Therefore, it falls under the Delisting Announcement category.
2026-01-06 French
Informations privilégiées / Autres communiqués
Legal Proceedings Report Classification · 1% confidence The document is a press release from CARMAT announcing the outcome of a judicial reorganization procedure (redressement judiciaire) and the approval of a disposal plan (plan de cession) by the Versailles Tribunal. It details the transfer of assets to a new entity (CARMAT SAS), the likely liquidation of the current listed entity (CARMAT SA), and the impending delisting of its shares. While it touches on financial restructuring, it is primarily a regulatory announcement regarding the company's corporate status and stock exchange listing. Given the specific nature of the announcement regarding the company's survival and listing status, 'RNS' (Regulatory Filings) is the most appropriate classification as it serves as the fallback for significant corporate regulatory updates that do not fit into specific categories like M&A or simple capital changes.
2025-12-02 French
Inside Information / Other news releases
Legal Proceedings Report Classification · 1% confidence The document is a press release from CARMAT providing an update on a receivership procedure and the court-approved sale plan of the company's assets to a new entity (CARMAT SAS). It discusses the implications for shareholders (likely total loss of value) and the impending delisting of the company's shares from Euronext Growth. While it mentions delisting, it is primarily a corporate update on the restructuring and receivership process. Since it does not fit into specific categories like M&A (which usually implies a merger or acquisition of a healthy entity) or simple regulatory filings, and given the significant nature of the receivership and liquidation announcement, it is best classified as a Regulatory Filing (RNS) as it serves as a general corporate announcement regarding material events.
2025-12-02 English
Inside Information / Other news releases
Legal Proceedings Report Classification · 1% confidence The document is a press release from CARMAT providing an update on its ongoing receivership procedure and the receipt of a takeover bid. While it discusses a potential sales plan (M&A context), it is primarily an update on the company's insolvency/receivership status and the potential for liquidation. Given the specific nature of the update regarding the receivership and the potential for delisting, it falls under the category of M&A activity (takeover bid) and corporate restructuring. Since the document details a specific takeover bid within a sales plan, 'TAR' (M&A Activity) is the most accurate classification.
2025-11-04 English
Informations privilégiées / Autres communiqués
Legal Proceedings Report Classification · 1% confidence The document is a press release from CARMAT regarding the status of its ongoing judicial reorganization (redressement judiciaire) and the receipt of a takeover offer. It details the legal proceedings, the potential for liquidation, and the impact on shareholders. While it discusses corporate restructuring, it does not fit the specific 'M&A' (TAR) category as it is a distressed asset situation under court supervision, nor is it a standard regulatory filing. It is a corporate announcement regarding material business developments, which falls under the 'Regulatory Filings' (RNS) category as a fallback for significant corporate updates that do not fit other specific categories.
2025-11-04 French
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is a press release issued by CARMAT announcing the postponement of its 2025 half-year financial report due to ongoing judicial reorganization proceedings. It does not contain the financial report itself, but rather serves as an official announcement regarding the timing and publication status of that report. According to the 'Menu vs Meal' rule, an announcement regarding the timing or publication of a report is classified as a Report Publication Announcement (RPA).
2025-10-29 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.